Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 5,209-5,220 of 10,592
Drug study icon
CompletedNCT02477670

Efficacy, Safety, and Tolerability of AVP-786 for Residual Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02153502

AVP-786 for depression

This study is completed in the United States. It is testing AVP-786 for depression.

In United States
DepressionDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
Drug study icon
CompletedNCT05545111

Safety study of NBI-1117568 in schizophrenia

This study is completed in the United States. It is testing NBI-1117568 for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05178121

eLearning for Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SuicidalityBehavioralOver 18 Years
Countries
United States
Sponsor
University of Washington
Condition
Suicidality
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.